Sharif Kayali

Dr. Sharif Kayali


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2021 in Hearts
Verified
Journal Article
Open access
PDF file
IPIssa Pour-Ghaz
Issa Pour-Ghaz
SKSharif Kayali
Sharif Kayali
IAIman Abutineh
Iman Abutineh
JPJay Patel
Jay Patel
SRSherif Roman
Sherif Roman
NYNeeraja Yedlapati
Neeraja Yedlapati
Sarcoidosis is a chronic multi-system disorder with an unknown etiology that can affect the cardiac tissue, resulting in Cardiac Sarcoidosis (CS). The majority of these CS cases are clinically silent, and when there are symptoms, the symptoms are vague and can have a lot in common with other common cardiac diseases. These symptoms can range from arrhythmias to heart failure. If CS goes undetected, it can lead to detrimental outcomes for patients. Diagnosis depends on timely utilization of imaging modalities and non-invasive testing, while in some cases, it does necessitate biopsy. Early diagnosis and treatment with immunosuppressive agents are crucial, and it is essential that follow-up testing be performed to ensure resolution and remission. This manuscript provides an in-depth review of CS and the current literature regarding CS diagnosis and treatment.

1 March 2022 in Current Cardiology Reviews
Verified
Journal Article
Open access
PDF file
IPIssa Pour-Ghaz
Issa Pour-Ghaz
MHMark Heckle
Mark Heckle
IIIkechukwu Ifedili
Ikechukwu Ifedili
SKSharif Kayali
Sharif Kayali
CNChristopher Nance
Christopher Nance
YLYehoshua C. Levine
Yehoshua C. Levine
: Implantable Cardioverter-Defibrillator (ICD) therapy is indicated for patients at risk for sudden cardiac death due to ventricular tachyarrhythmia. The most commonly used risk stratification algorithms use Left Ventricular Ejection Fraction (LVEF) to determine which patients qualify for ICD therapy, even though LVEF is a better marker of total mortality than ventricular tachyarrhythmias mortality. This review evaluates imaging tools and novel biomarkers proposed for better risk stratifying arrhythmic substrate, thereby identifying optimal ICD therapy candidates.

23 February 2024 in Current Problems in Cardiology
Verified
Journal Article
Closed access
SKSharif Kayali
Sharif Kayali
BDBernhard E. Dietz
Bernhard E. Dietz
BSBilal S. Siddiq
Bilal S. Siddiq
MGMichael Ghaly
Michael Ghaly
TOTimothy S. Owens
Timothy S. Owens
RKRami N. Khouzam
Rami N. Khouzam

4 January 2024 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
IIIkechukwu Ifedili
Ikechukwu Ifedili
MMMiguel Maturana
Miguel Maturana
SKSharif Kayali
Sharif Kayali
YLYehoshua Levine
Yehoshua Levine
RKRajesh Kabra
Rajesh Kabra
SJSunil K. Jha
Sunil K. Jha

1 August 2021 in Heart Rhythm
Verified
Journal Article
Closed access
MHMark Heckle
Mark Heckle
IPIssa Pour-Ghaz
Issa Pour-Ghaz
IIIke Ifedili
Ike Ifedili
IMIbrahim El Masri
Ibrahim El Masri
DJDavid Jones
David Jones
YLYehoshua C. Levine
Yehoshua C. Levine

10 October 2020 in Current Treatment Options in Cardiovascular Medicine
Verified
Journal Article
Closed access
PDF file
IMIbrahim El Masri
Ibrahim El Masri
SKSharif Kayali
Sharif Kayali
TMTheodore Manolukas
Theodore Manolukas
YLYehoshua C. Levine
Yehoshua C. Levine